000 01548nam  2200337zi 4500
0019.905486
003CaOODSP
00520221107180839
006m     o  d f      
007cr cn|||||||||
008211130t20222022oncd    o s  f000 0 eng d
020 |a9780660411354
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH82-53/2022E-PDF
24500|aExpensive drugs for rare diseases : |bCanadian trends and international comparisons, 2011–2020.
264 1|aOttawa, ON : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c2022.
264 4|c©2022
300 |a1 online resource (30 pages) : |bcharts
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Médicaments onéreux pour les maladies rares : tendances canadiennes et comparaisons internationales, 2011-2020.
500 |aIssued also in HTML format.
650 0|aDrugs|xPrices|zCanada.
650 0|aRare diseases|zCanada.
7101 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body.
77508|tMédicaments onéreux pour les maladies rares : |w(CaOODSP)9.905487
85640|qPDF|s1.12 MB|uhttps://publications.gc.ca/collections/collection_2022/cepmb-pmprb/H82-53-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/chartbook/expensive-drugs-rare-diseases-2011-2020.html